Skip to main content

Featured

5 Things to Know Today: TSX Recap, Oil Eases, Loonie Under Pressure & Alberta's Pipeline Announcement (July 3, 2026)

  Friday, July 3, 2026 Here's what's moving markets and your money this morning — from Bay Street to the pumps to Ottawa. 1. TSX gains as investors digest a mixed session The S&P/TSX Composite closed up 0.31% on Thursday at 34,966.67 points (+109.68), its first full trading day back after the Canada Day holiday. Financials were mixed — Brookfield edged higher while TD Bank slipped nearly 1% — but mining stocks got a lift as gold prices ticked up, with Barrick and Franco-Nevada both up more than 3%. Shopify was the standout, jumping over 5% after settling a dispute with Shopline. 2. Oil prices ease as Iran-US talks continue in Doha Crude prices pulled back further and are now trading closer to pre-conflict levels after another round of indirect US-Iran talks in Doha, even though the sides didn't reach a breakthrough. That's welcome news for anyone filling up this long weekend, and it's also easing some of the energy-driven inflation pressure that's been compl...

article

Health Canada authorizes updated Pfizer-BioNTech COVID vaccine


Health Canada has authorized Pfizer-BioNTech’s updated COVID-19 vaccine for people six months and older.

The mRNA vaccine targets the Omicron XBB.1.5 subvariant that is circulating in Canada.

This is the second vaccine targeting XBB.1.5 that will be available in this country.

Earlier this month, Health Canada authorized Moderna's updated mRNA vaccine.

Both Pfizer and Moderna's shots are one-dose vaccines for people five years of age and older.

Three shots of the Pfizer vaccine is recommended for children between six months and four years of age who have not received their primary series of a COVID-19 vaccine.

Health Canada says it is currently reviewing an updated non-mRNA vaccine from Novavax.

Novavax’s vaccine has been submitted for consideration for people age 12 years and older.

Comments